Article info
Original Article
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
- Correspondence to Saul Eugene Rivkin; saul.rivkin{at}swedish.org
Citation
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Publication history
- Received April 23, 2018
- Revision received September 5, 2018
- Accepted September 7, 2018
- First published January 29, 2019.
Online issue publication
February 04, 2019
Article Versions
- Previous version (29 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.